Phreesia Inc. (PHR) Tops Q2 EPS by 7c, provides guidance

Phreesia Inc. (NYSE: PHR) reported Q2 EPS of $0.01, $0.07 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $117.3 million versus the consensus estimate of $116.54 million.

GUIDANCE:

Phreesia Inc. sees FY2026 revenue of $472-482 million, versus the consensus of $476.7 million.

For earnings history and earnings-related data on Phreesia Inc. (PHR) click here.

You May Also Be Interested In

• BofA maintains underperform ratings on six BDC stocks
• Nuvectis Pharma (NVCT) files $200M mixed shelf
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance